Progress in Medicinal Chemistry (eBook, ePUB)

• Format: ePub

Produktbeschreibung

Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume includes chapters covering recent advances in cancer therapeutics, fluorine in medicinal chemistry, a perspective on the next generation of antibacterial agents derived by manipulation of natural products, a new era for Chagas Disease drug discovery? and imaging in drug development. - Extended timely reviews of topics in medicinal chemistry - Targets and technologies relevant to the discovery of tomorrow's drugs - Analyses of successful drug discovery programmes

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 314
• Erscheinungstermin: 2. Februar 2015
• Englisch
• ISBN-13: 9780444634856
• Artikelnr.: 43851715

Autorenporträt

Dr Geoff Lawton has extensive experience in new medicine discovery across many therapeutic areas in both large and small companies and is a co-inventor of a marketed drug (Cilazapril). He is a former Director of Chemistry at Roche UK, and Vice-president Chemistry and Preclinical Sciences within Roche Bioscience, Palo Alto, USA. He was for five years the research member of a global therapy area strategy planning team for inflammatory diseases, aligning research with the clinical development and marketing parts of the business.
From 2003 to 2007 he was founding Research Director with Lectus Therapeutics building from start-up a drug discovery organisation; generating the team, facilities and project portfolio targeting the next generation of ion channel modulating medicines.

Since 2001 Geoff has provided scientific and strategic evaluation and advice on drug discovery as an independent consultant for a number small and medium sized biotech companies, CROs, VCs, academic groups and medical research charities.

Geoff serves on the Board of Antabio, a French biotech company developing tomorrow's antibacterial drugs.

He is a founder of INMedD, a new medicines discovery social enterprise.

Inhaltsangabe

1. Recent Advances in Cancer TherapeuticsNicola Chessum, Keith Jones, Elisa Pasqua and Michael Tucker2. Fluorine in Medicinal ChemistrySteven Swallow3. A Perspective on the Next Generation of Antibacterial Agents Derived by Manipulation of Natural Products Pamela Brown and Michael J. Dawson4. A New Era for Chagas Disease Drug Discovery?Martine Keenan and Jason H. Chaplin5. Imaging in Drug DevelopmentJames Nairne, Peter B. Iveson and Andreas Meijer